Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference
September 19 2017 - 10:00AM
PR Newswire (US)
BOULDER, Colo., Sept. 19, 2017 /PRNewswire/ -- Array
BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Ron Squarer, will
present at the 2017 Cantor Fitzgerald Global Healthcare
Conference. The public is welcome to participate in the
conference through a webcast on the Array BioPharma
website.
|
Event:
|
Cantor Fitzgerald
Global Healthcare Conference
|
|
Presenter:
|
Ron Squarer, Chief
Executive Officer
|
|
Date:
|
Tuesday, September
26, 2017
|
|
Time:
|
8:35 a.m. Eastern
Time
|
|
Webcast:
|
http://wsw.com/webcast/cantor6/arry/
|
About Array BioPharma
Array BioPharma Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of targeted small molecule drugs to treat
patients afflicted with cancer. Eight registration studies
are currently advancing related to seven Array-owned or partnered
drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib
(partnered with AstraZeneca), danoprevir (partnered with Roche),
ipatasertib (partnered with Genentech), larotrectinib (partnered
with Loxo Oncology) and tucatinib (partnered with Cascadian
Therapeutics).
|
CONTACT:
|
Tricia
Haugeto
|
|
Array BioPharma
Inc.
|
|
303-386-1193
|
|
thaugeto@arraybiopharma.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-cantor-fitzgerald-global-healthcare-conference-300520754.html
SOURCE Array BioPharma Inc.
Copyright 2017 PR Newswire
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Array Technologies (NASDAQ:ARRY)
Historical Stock Chart
From Apr 2023 to Apr 2024
